Biomarin Pharmaceutical Inc (BMRN)
82.44
-1.36
(-1.62%)
USD |
NASDAQ |
May 03, 16:00
82.46
+0.02
(+0.03%)
After-Hours: 20:00
Biomarin Pharmaceutical Total Return Level: 82.44 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 82.44 |
May 02, 2024 | 83.80 |
May 01, 2024 | 83.33 |
April 30, 2024 | 80.76 |
April 29, 2024 | 82.13 |
April 26, 2024 | 80.91 |
April 25, 2024 | 82.17 |
April 24, 2024 | 91.20 |
April 23, 2024 | 92.06 |
April 22, 2024 | 89.49 |
April 19, 2024 | 88.63 |
April 18, 2024 | 90.07 |
April 17, 2024 | 90.47 |
April 16, 2024 | 90.87 |
April 15, 2024 | 91.51 |
April 12, 2024 | 92.22 |
April 11, 2024 | 91.46 |
April 10, 2024 | 90.21 |
April 09, 2024 | 88.98 |
April 08, 2024 | 87.28 |
April 05, 2024 | 86.95 |
April 04, 2024 | 86.89 |
April 03, 2024 | 86.78 |
April 02, 2024 | 86.80 |
April 01, 2024 | 87.10 |
Date | Value |
---|---|
March 28, 2024 | 87.34 |
March 27, 2024 | 88.61 |
March 26, 2024 | 87.74 |
March 25, 2024 | 86.52 |
March 22, 2024 | 85.13 |
March 21, 2024 | 84.11 |
March 20, 2024 | 84.76 |
March 19, 2024 | 85.27 |
March 18, 2024 | 83.81 |
March 15, 2024 | 83.87 |
March 14, 2024 | 84.39 |
March 13, 2024 | 84.77 |
March 12, 2024 | 85.18 |
March 11, 2024 | 86.00 |
March 08, 2024 | 85.95 |
March 07, 2024 | 85.89 |
March 06, 2024 | 86.77 |
March 05, 2024 | 86.02 |
March 04, 2024 | 87.72 |
March 01, 2024 | 87.14 |
February 29, 2024 | 86.28 |
February 28, 2024 | 88.40 |
February 27, 2024 | 90.68 |
February 26, 2024 | 90.10 |
February 23, 2024 | 91.24 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
64.27
Minimum
Oct 02 2019
131.03
Maximum
Jul 20 2020
86.84
Average
85.23
Median
Jul 22 2022
Total Return Level Benchmarks
Pfizer Inc | 95.05 |
Eli Lilly and Co | 2115.57 |
Merck & Co Inc | 428.38 |
Bristol-Myers Squibb Co | 176.02 |
Moderna Inc | 125.00 |